Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
- Study type
- Clinical guideline
- Study name
- ESMO Cancer-Related Fatigue 2020
- Design
- Clinical guideline (ESMO Clinical Practice Guidelines)
- Source
- Annals of Oncology · 2020
In plain words
This article is a guideline from the European Society for Medical Oncology (ESMO) on the diagnosis and treatment of cancer-related fatigue. Fatigue is one of the most common problems for people with cancer. To find out the exact recommendations, talk to your treating doctor.
Study population
The PubMed record of this article has no abstract. The target population of the guideline (patients with cancer-related fatigue) is inferred from the title, and details are in the full text of the paper.
Endpoints
Not applicable. This article is a clinical guideline, not a trial. Methodological details are in the full text of the paper.
Safety and side effects
The available record (no abstract) contains no information on adverse effects of treatments. Details are in the full text of the paper.
Clinical significance and place in guidelines
This card is based only on the title and publication details of the paper, as the record had no abstract. The content of the recommendations and their levels of evidence should be extracted from the full text of the guideline and confirmed by a reviewing oncologist. The current status of the guideline (later updates) should also be checked.
Limitations
The source record has no abstract, and no recommendations, statistics or levels of evidence could be extracted from it. The card is incomplete until it is completed from the full text of the paper.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.